The Relationship between Pre-Pandemic Interferon Gamma Release Assay Test Results and COVID-19 Infection: Potential Prognostic Value of Indeterminate IFN-
Journal
The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale
ISSN: 1712-9532
Titre abrégé: Can J Infect Dis Med Microbiol
Pays: Egypt
ID NLM: 101226876
Informations de publication
Date de publication:
2021
2021
Historique:
received:
07
06
2021
accepted:
23
07
2021
entrez:
9
8
2021
pubmed:
10
8
2021
medline:
10
8
2021
Statut:
epublish
Résumé
To reveal the relationship between interferon-gamma release assay (IGRA) test (Standard ETB-Feron ELISA (TBF)) results performed within 12 months before the COVID-19 pandemic and the frequency of COVID-19 infections and the severity of COVID-19. The retrospective TBF test results and contact information of 684 patients aged over 18 years who underwent TBF testing between March 11th, 2019, and March 10th, 2020, were obtained. Of the 684 patients contacted by phone, 365 agreed to participate in the study and were enrolled. The patients were divided into three groups (TBF test positive, negative, and indeterminate). The data obtained from the questionnaire were compared statistically. According to the TBF test results, positive ( The frequency of COVID-19 infection was increased in patients with indeterminate TBF test results. Indeterminate TBF test results may be a guide in terms of risk stratification in groups at risk for COVID-19.
Identifiants
pubmed: 34367385
doi: 10.1155/2021/1989277
pmc: PMC8342180
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1989277Informations de copyright
Copyright © 2021 Sermin Borekci et al.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest regarding the publication of this paper.
Références
J Clin Med. 2021 Feb 26;10(5):
pubmed: 33652893
Respir Med. 2020 Sep;171:106096
pubmed: 32763754
Am J Infect Control. 2021 Jan;49(1):82-89
pubmed: 32540370
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Sci Immunol. 2020 Jun 26;5(48):
pubmed: 32591408
Am J Respir Crit Care Med. 2014 Nov 15;190(10):1168-76
pubmed: 25303140
J Clin Microbiol. 2012 Aug;50(8):2767-9
pubmed: 22593598
Ann Intern Med. 2008 Aug 5;149(3):177-84
pubmed: 18593687
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32817205
Cell Immunol. 2021 Jul;365:104363
pubmed: 33905951
New Microbiol. 2007 Jul;30(3):286-90
pubmed: 17802911
Nat Rev Immunol. 2018 Sep;18(9):545-558
pubmed: 29921905
Med Hypotheses. 2020 Nov;144:110214
pubmed: 33254521
Respir Med. 2020 Dec;175:106204
pubmed: 33186846
Dev Cell. 2020 Jun 8;53(5):514-529.e3
pubmed: 32425701
Clin Infect Dis. 2020 Oct 09;:
pubmed: 33035306
Clin Immunol. 2021 Mar;224:108651
pubmed: 33333255
Eur Respir J. 2017 Oct 26;50(4):
pubmed: 29074546
J Clin Microbiol. 2019 Nov 22;57(12):
pubmed: 31533984
Clin Microbiol Rev. 2014 Jan;27(1):3-20
pubmed: 24396134
J Infect Public Health. 2020 Nov;13(11):1619-1629
pubmed: 32718895
Int J Infect Dis. 2021 Apr;105:21-25
pubmed: 33582369
Obes Res. 1998 Sep;6 Suppl 2:51S-209S
pubmed: 9813653